SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...

The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments ...

Monoclonal antibodies like etesevimab have lost efficacy against Omicron subvariants, necessitating innovative solutions.

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is ...

Lower efficiency than Covid-19: While it can infect human cells, scientists have said its ability to do so is significantly weaker than SARS-CoV-2. The research team, led by Shi Zhengli ...

A Chinese team of virologists has found that this virus ... Scientists found that the new virus can bind to human ACE2, making it similar to SARS-CoV-2 and NL63 (a common cold virus).